No New Trial for the 3rd Xarelto Bellwether Plaintiff
No New Trial for the 3rd Xarelto Bellwether Plaintiff
Introduction
The plaintiff of the 3rd Xarelto bellwether trial, which went in favor of the Xarelto defendants J&J's Janssen Pharmaceuticals and Bayer in August 2017, faced a defeat again when a Louisiana federal judge turned down the request for a new trial.
The plaintiff had planned for a retrial based on the recent scientific study that she hoped could change the jury's mind. Judge Eldon E. Fallon denied her request stating that the newly discovered evidence was actually cumulative of the previously known and admitted evidence.
Xarelto lawsuits are consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana; nearly 22,000 cases are a part of this MDL while more than 1,500 cases are pending in Philadelphia's Complex Litigation Center.
Comments
Latest News
Lawyers to Meet Nov. 5 for Talcum Powder Trial Prep
Categories: Talcum
As the first federal talcum powder bellwether trial approaches, both plaintiffs and defendants have finalized their legal teams and are preparing for a key pretrial conference scheduled for early November.
The upcoming proceedings mark a…
2025 Update: What to Know About PPI Lawsuit Settlements & Payout Dates
Categories: Settlements
Last updated on Oct 27, 2025.
The mass tort litigation involving proton pump inhibitor (PPI) drugs — such as Nexium, Prilosec, Prevacid and Protonix — is entering a pivotal phase in …
New Front Emerges in Fight Against Synthetic Opioids
Categories: Opioids
The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…